Millard F - Search Results

1

Are repeat prostate biopsies safe? A cohort analysis from the SEARCH database.

Kopp RP, Stroup SP, Schroeck FR, Freedland SJ, Millard F, Terris MK, Aronson WJ, Presti JC Jr, Amling CL, Kane CJ. Kopp RP, et al. Among authors: millard f. J Urol. 2012 Jun;187(6):2056-60. doi: 10.1016/j.juro.2012.01.083. Epub 2012 Apr 11. J Urol. 2012. PMID: 22498218 Free PMC article.

2

Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study.

Stroup SP, Raheem OA, Palazzi KL, Liss MA, Mehrazin R, Kopp RP, Patel N, Cohen SA, Park SK, Patterson AL, Kane CJ, Millard F, Derweesh IH. Stroup SP, et al. Among authors: millard f. Urology. 2013 Apr;81(4):805-11. doi: 10.1016/j.urology.2012.10.054. Epub 2013 Feb 13. Urology. 2013. PMID: 23414694

3

Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approaches.

Patel N, Woo J, Liss MA, Palazzi KL, Randall JM, Mehrazin R, Jabaj R, Mirheydar HS, Gillis K, Lee HJ, Patterson AL, Kane CJ, Millard F, Derweesh IH. Patel N, et al. Among authors: millard f. Can J Urol. 2016 Apr;23(2):8227-33. Can J Urol. 2016. PMID: 27085828 Clinical Trial.

4

Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer.

Nath SK, Sandhu AP, Rose BS, Simpson DR, Nobiensky PD, Wang JZ, Millard F, Kane CJ, Parsons JK, Mundt AJ. Nath SK, et al. Among authors: millard f. Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):435-41. doi: 10.1016/j.ijrobp.2009.08.023. Epub 2009 Nov 24. Int J Radiat Oncol Biol Phys. 2010. PMID: 19939580

5

What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?

Mirheydar HS, Banapour P, Massoudi R, Palazzi KL, Jabaji R, Reid EG, Millard FE, Kane CJ, Sur RL. Mirheydar HS, et al. Int Braz J Urol. 2014 Nov-Dec;40(6):772-80. doi: 10.1590/S1677-5538.IBJU.2014.06.08. Int Braz J Urol. 2014. PMID: 25615245 Free article.

6

Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery.

Silberstein JL, Millard F, Mehrazin R, Kopp R, Bazzi W, DiBlasio CJ, Patterson AL, Downs TM, Yunus F, Kane CJ, Derweesh IH. Silberstein JL, et al. Among authors: millard f. BJU Int. 2010 Nov;106(9):1270-6. doi: 10.1111/j.1464-410X.2010.09357.x. BJU Int. 2010. PMID: 20394613

7

Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis.

Field CA, Cotta BH, Jimenez J, Lane BR, Yim K, Lee HJ, Ryan ST, Hamilton ZA, Patel S, Wang S, Kane CJ, Dey S, Mckay RR, Noyes S, Millard FE, Rini BI, Campbell SC, Derweesh IH. Field CA, et al. Clin Genitourin Cancer. 2019 Jun;17(3):e505-e512. doi: 10.1016/j.clgc.2019.01.013. Epub 2019 Jan 30. Clin Genitourin Cancer. 2019. PMID: 30808547

8

Target localization and toxicity in dose-escalated prostate radiotherapy with image-guided approach using daily planar kilovoltage imaging.

Nath SK, Sandhu AP, Sethi RA, Jensen LG, Rosario MD, Kane CJ, Parsons JK, Millard FE, Jiang SB, Rice RK, Pawlicki T, Mundt AJ. Nath SK, et al. Among authors: millard fe. Technol Cancer Res Treat. 2011 Feb;10(1):31-7. doi: 10.7785/tcrt.2012.500177. Technol Cancer Res Treat. 2011. PMID: 21214286 Free article.

9

Change in platelet count as a prognostic indicator for response to primary tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma.

Hamilton Z, Lee HJ, Jimenez J, Lane BR, Wang S, Beksac AT, Gillis K, Alagh A, Tobert C, Randall JM, Kane CJ, Millard F, Campbell SC, Derweesh IH. Hamilton Z, et al. Among authors: millard f. BJU Int. 2016 Dec;118(6):927-934. doi: 10.1111/bju.13490. Epub 2016 May 11. BJU Int. 2016. PMID: 27008916

10

Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.

Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page